Hemodynamic arteriosclerotic syndrome – A vicious cycle of hemodynamic stress and vascular disease

Kazuomi Kario

doi:10.1111/jch.13313

Hemodynamic arteriosclerotic syndrome – A vicious cycle of hemodynamic stress and vascular disease

Research output: Contribution to journal › Editorial

12 Scopus citations

Original language	English
Pages (from-to)	1073-1077
Number of pages	5
Journal	Journal of Clinical Hypertension
Volume	20
Issue number	6
DOIs	https://doi.org/10.1111/jch.13313
State	Published - Jun 2018
Externally published	Yes

Access to Document

10.1111/jch.13313

Cite this

@article{cb5aa7e74784498d869f4bbcc22fde17,

title = "Hemodynamic arteriosclerotic syndrome – A vicious cycle of hemodynamic stress and vascular disease",

author = "Kazuomi Kario",

note = "Funding Information: K. Kario has received research funding from Teijin Pharma Limited, Omron Healthcare Co., Ltd., Fukuda Denshi, Bayer Yakuhin Ltd., A &D Co., Ltd., Daiichi Sankyo Company, Limited, Mochida Pharmaceutical Co., Ltd, EA pharma, Boehringer Ingelheim Japan Inc., Tanabe Mitsubishi Pharma Corporation, Shionogi & Co., Ltd., MSD K.K., Sanwa Kagaku Kenkyusho Co.,LTD., Bristol-Myers Squibb K.K., and honoraria from Takeda Pharmaceutical Company Limited and Omron Healthcare Co., Ltd outside the submitted work.",

year = "2018",

month = jun,

doi = "10.1111/jch.13313",

language = "English",

volume = "20",

pages = "1073--1077",

journal = "Journal of Clinical Hypertension",

issn = "1524-6175",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

TY - JOUR

T1 - Hemodynamic arteriosclerotic syndrome – A vicious cycle of hemodynamic stress and vascular disease

AU - Kario, Kazuomi

N1 - Funding Information: K. Kario has received research funding from Teijin Pharma Limited, Omron Healthcare Co., Ltd., Fukuda Denshi, Bayer Yakuhin Ltd., A &D Co., Ltd., Daiichi Sankyo Company, Limited, Mochida Pharmaceutical Co., Ltd, EA pharma, Boehringer Ingelheim Japan Inc., Tanabe Mitsubishi Pharma Corporation, Shionogi & Co., Ltd., MSD K.K., Sanwa Kagaku Kenkyusho Co.,LTD., Bristol-Myers Squibb K.K., and honoraria from Takeda Pharmaceutical Company Limited and Omron Healthcare Co., Ltd outside the submitted work.

PY - 2018/6

Y1 - 2018/6

UR - http://www.scopus.com/inward/record.url?scp=85047666370&partnerID=8YFLogxK

U2 - 10.1111/jch.13313

DO - 10.1111/jch.13313

M3 - Editorial

C2 - 29806107

AN - SCOPUS:85047666370

SN - 1524-6175

VL - 20

SP - 1073

EP - 1077

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

IS - 6

ER -